GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (STU:USJ) » Definitions » Cyclically Adjusted Revenue per Share

Usana Health Sciences (STU:USJ) Cyclically Adjusted Revenue per Share : €49.70 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Usana Health Sciences Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Usana Health Sciences's adjusted revenue per share for the three months ended in Mar. 2024 was €10.858. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €49.70 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Usana Health Sciences's average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Usana Health Sciences was 26.80% per year. The lowest was 11.50% per year. And the median was 15.25% per year.

As of today (2024-05-27), Usana Health Sciences's current stock price is €42.40. Usana Health Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €49.70. Usana Health Sciences's Cyclically Adjusted PS Ratio of today is 0.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Usana Health Sciences was 4.53. The lowest was 0.80. And the median was 2.36.


Usana Health Sciences Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Usana Health Sciences's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences Cyclically Adjusted Revenue per Share Chart

Usana Health Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.97 31.14 39.16 46.50 47.66

Usana Health Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.61 47.33 49.38 47.66 49.70

Competitive Comparison of Usana Health Sciences's Cyclically Adjusted Revenue per Share

For the Packaged Foods subindustry, Usana Health Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Usana Health Sciences's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's Cyclically Adjusted PS Ratio falls into.



Usana Health Sciences Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Usana Health Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.858/131.7762*131.7762
=10.858

Current CPI (Mar. 2024) = 131.7762.

Usana Health Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.867 100.560 6.378
201409 5.615 100.428 7.368
201412 7.184 99.070 9.556
201503 7.746 99.621 10.246
201506 7.857 100.684 10.283
201509 7.804 100.392 10.244
201512 8.160 99.792 10.775
201603 8.574 100.470 11.246
201606 9.234 101.688 11.966
201609 9.042 101.861 11.698
201612 9.575 101.863 12.387
201703 9.558 102.862 12.245
201706 9.145 103.349 11.660
201709 8.932 104.136 11.303
201712 9.529 104.011 12.073
201803 9.756 105.290 12.210
201806 10.388 106.317 12.876
201809 10.173 106.507 12.587
201812 10.749 105.998 13.363
201903 10.097 107.251 12.406
201906 9.695 108.070 11.822
201909 10.648 108.329 12.953
201912 11.225 108.420 13.643
202003 11.196 108.902 13.548
202006 10.885 108.767 13.188
202009 11.972 109.815 14.366
202012 12.054 109.897 14.454
202103 12.263 111.754 14.460
202106 13.674 114.631 15.719
202109 11.570 115.734 13.174
202112 12.024 117.630 13.470
202203 12.718 121.301 13.816
202206 13.001 125.017 13.704
202209 12.239 125.227 12.879
202212 11.170 125.222 11.755
202303 12.002 127.348 12.419
202306 11.317 128.729 11.585
202309 10.320 129.860 10.472
202312 10.530 129.419 10.722
202403 10.858 131.776 10.858

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Usana Health Sciences  (STU:USJ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Usana Health Sciences's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=42.40/49.7
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Usana Health Sciences was 4.53. The lowest was 0.80. And the median was 2.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Usana Health Sciences Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Usana Health Sciences (STU:USJ) Business Description

Traded in Other Exchanges
Address
3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Usana Health Sciences (STU:USJ) Headlines

No Headlines